This is not legal under federal compounding rules, which require a drug to be either FDA approved or on the official FDA shortage list, neither of which applies to retatrutide
A patient who loses 15% of body weight on semaglutide and one who loses 1% are, from a mechanistic standpoint, providing different information about the receptor, the circuit, the microbiome, and the adipose biology underlying their metabolic disease
This loss in fat mass might be what is causing you to feel chills with Ozempic, because your bodys insulation is diminishing, and subsequently your metabolism is changing
Micellar effect of CTAB on phenol red sodium salt: a model system may be used for cell membrane study
Decisions should be individualized based on the patients overall risk profile, benefits of therapy, and clinical judgment
Youll need to do this after each injection because you will use a new needle for each dose